TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to introduce CleanScribe™ RNA Polymerase. This novel enzyme reduces the formation of double-stranded RNA (dsRNA) by up to 85% during in vitro transcription (IVT) for mRNA production, a key
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has announced the opening of its new cGMP mRNA manufacturing facility in San Diego. The facility, spanning 32,000 square feet, has been specifically designed to
TriLink Biotechnologies is a company operating in the pharmaceutical industry. TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
